Skip to main content

Immunogenetics in Pathogenesis of and Protection Against Toxoplasmosis

  • Chapter
Toxoplasma gondii

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 219))

Abstract

Clinical manifestations and congenital transmission rates vary markedly among individuals with Toxoplasma infection (reviewed in Boyer and McLeod 1996; Remington et al. 1995). An influence of host immune response genes on the outcome of congenital infection is supported by observations of concordance of manifestations in monozygotic versus discordance of manifestations in dizygotic twins (Couvreur et al. 1976; reviewed in Remington et al. 1995), ethnic variations in incidence and severity of manifestations of disease (McAuley et al. 1994) and recent HLA typing studies (Mack et al. 1996b). Data from studies of murine models indicate that variables such as parasite strain (McLeod et al. 1984, 1988; Suzuki et al. 1989; Sibley and Boothroyd 1992; Suzuki and Joh 1994), inoculum size (Johnson et al., unpublished), host age (Johnson et al. unpublished), sex hormones (Roberts et al. 1995), and immune status (Gazzinelli et al. 1993a,b) also clearly modulate and effect outcome of infection. Studies are under way to define precisely how host genetics, as well as certain of the variables mentioned above, determine the small proportion of immunologically competent older children and adults who develop various disease manifestations. These studies are focused on the role of genetics in determining disease manifestations such as those described in systemic (reviewed in Boyer and McLeod 1996), retinal (Couvreur and Thulliez 1996), neurologic disease (Townsend et al. 1975), or lymphadenopathic toxoplasmosis (McCabe et al. 1987; Montoya and Remington 1995). In addition, these studies address whether immunogenetics influence the small proportion of acutely infected women who transmit infection to their fetuses early in gestation (Hohfeld et al. 1994), the 40% of T. gondii seropositive patients with AIDS who develop toxoplasmic encephalitis (Luft and Remington 1992), the severity of manifestations of congenital infection (McAuley et al. 1994; Mack et al. 1996b) or the occurrence or frequency of episodes of reactivation in recurrent retinochoroiditis in individuals with toxoplasmic retinochoroiditis (Mets et al. 1992; Mets et al. 1996).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abbas AK, Lichtman AH, Pober JS (1991) Cellular and molecular immunology. Saunders, Philadelphia

    Google Scholar 

  • Aosai F, Yang TH, Ueda M, Yano A (1994): Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. J Parasitol 80:260–266

    Article  PubMed  CAS  Google Scholar 

  • Beaman MH, Araujo FG, Remington JS (1994) Protective reconstitution of the SCID mouse against reactivation of toxoplasmic encephalitis. J Infect Dis 160:375–383

    Article  Google Scholar 

  • Blackwell J, Roberts CW, Alexander J (1993) Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immun 15:317–324

    Article  CAS  Google Scholar 

  • Blackwell JM, Roberts CW, Roach TI, Alexander J (1994) Inlluence of macrophage resistance gene LSH/ITy/Bcg (candidate NRamp on Toxoplasma gondii infection in mice). Clin Exp Immunol 97:107–112

    Article  PubMed  CAS  Google Scholar 

  • Bodner JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HD, Mach B, Mayr WR, Patnam P, Sasazuld T (1994) Nomenclature report: nomenclature lor lactors of the HLA system. Tissue Antigens 44:1–18

    Article  Google Scholar 

  • Bohne W, Heesemann J, Gross U (1994) Reduced replication of Toxoplasma gondii is necessary lor induction of bradyzoite-specilic antigens: a possible role lor nitric oxide in triggering stage conversion. Infect Immun 62: 1761–1767

    PubMed  CAS  Google Scholar 

  • Boyer K, McLeod R (1996) Toxoplasma gondii and Toxoplasmosis. In: Long S, Proeber C, Pickering, L (eds) Pediatric infectious diseases. Churchill Livingstone (in press)

    Google Scholar 

  • Brown CR, McLeod R (1990) Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J Immunol 145:3438–3441

    PubMed  CAS  Google Scholar 

  • Brown CR, McLeod R (1994) Mechanisms of survival of mice during acute and chronic T. gondii infection. Parasitol Today 10:290–292

    Article  PubMed  CAS  Google Scholar 

  • Brown C, David C, Kahn SJ, McLeod R (1994) Effect of human MHC class I genes on outcome of T. gondii cyst formation. J Immunol 152:4537–4541

    PubMed  CAS  Google Scholar 

  • Brown CR, Hunter C, Estes R, Beckmann E, Forman J, David C, Remington JS, McLeod R... (1995) Delinitive identilication of a gene that conlers resistance against toxoplasmosis. Immunology 85:419–429

    PubMed  CAS  Google Scholar 

  • Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J (1994) Temporal differences in the expression of mRNA lor IL-10 and IFN-γ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite Immunol 15:305–314

    Article  Google Scholar 

  • Couvreur J, Desmonts G, Girre JY (1976) Congenital toxoplasmosis in twins. J Ped 69:235–240

    Article  Google Scholar 

  • Couvreur J, Thulliez P (1996) Toxoplasmose acquise a localisation oculaire ou neurologique — 49 cas. Presse Med 25:438–442

    PubMed  CAS  Google Scholar 

  • Deckert-Schlüter, Albrecht S, Hol H, Wiestier OD, Schlüter D (1995) Dynamics of the intracerebral and splenic mRNA production in Toxoplasma gondii-resistant and-susceptible congenic strains of mice. Immunology 85:408–419

    PubMed  Google Scholar 

  • Denkers E, Gazzinelli R, Martin D, Sher A (1993) Emergence of NK1,1+ cells as effectors of IFN-γ dependent immunity to Toxoplasma gondii in MHC class I deficient mice. J Exp Med 175:1465–1472

    Article  Google Scholar 

  • Denkers EY, Casper P, Sher A (1994) Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V ß 5 bearing CD8+ lymphocytes. J Exp Med 180:985–994

    Article  PubMed  CAS  Google Scholar 

  • Gazzinelli RT, Oswald IP, James SL, Sher A (1992) IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ activated macrophages. J Immunol 148: 1792–1796

    PubMed  CAS  Google Scholar 

  • Gazzinelli RT, Denkers EY, Sher A (1993a) Host resistance to Toxoplasma gondii, a model lor studying the selective induction of cell-mediated immunity by intracellular parasites. Infect Agents Dis 2139-149

    Google Scholar 

  • Gazzinelli RT, Eltoum I, Wynn TA, Sher A (1993b) Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-± and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 151:3672–3681

    PubMed  CAS  Google Scholar 

  • Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Casper P, Trinchieri G, Sher A (1994) Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153:2533–2543

    PubMed  CAS  Google Scholar 

  • Gazzinelli RT, Wysocka M, Hieny S, Kersten T, Carrera L, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A (1996) In the absence of endogenous IL-10 mice acutely inlected with Toxoplasma gondii succumb to alethal immune response associated with increased synthesis of IL-12, IFN-γ and TNF-α. J. Immunol. (in press)

    Google Scholar 

  • Hili AVS, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gai XM, Takiguchi M, Greenwood BM, Townsend AR (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434–439

    Article  Google Scholar 

  • Hohfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. N Engl J Med 331:695–699

    Article  Google Scholar 

  • Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Apella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2 by mass spectrometry. Science 255: 1261–1263

    Article  PubMed  CAS  Google Scholar 

  • Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of IFN-γ by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor-α. Infect Immun 62:2818–2824

    PubMed  CAS  Google Scholar 

  • Jones TC, Erb P (1985) H-2 Complex-linked resistance in murine toxoplasmosis. J Inf Dis 151:739–740

    Article  CAS  Google Scholar 

  • Johnson LL (1994) Resistanee to Toxoplasma gondii in mice infected as neonates or exposed in utero. Infect Immun 62:3075–3079

    PubMed  CAS  Google Scholar 

  • Kaufmann SHE (1994) Bacterial and protozoal infections in genetieally disrupted mice. Curr Opin Immunol 5:518–525

    Article  Google Scholar 

  • Khan IA, Matsuura T, Kasper LH (1994) Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 62: 1639–1642

    PubMed  CAS  Google Scholar 

  • Luft BJ, Remington JS (1992) Toxoplasmic eneephalitis in AIDS. Clin Inf Dis 15:211–222

    Article  CAS  Google Scholar 

  • Lukachar AE, Yupo M, Carroll JP, Abromson-Leeman SR, Laning C, Darf ME, Benjamin T (1995) Susceptibility to tumors indueed by polyoma virus is eonferred by an endogenous mouse mammary tumor virus superantigen. J Exp Med 151:1683–1692

    Article  Google Scholar 

  • Mack D, Estes RG, McLeod R (1996a) Toxoplasma gondii superantigen (manuscript in preparation)

    Google Scholar 

  • Mack D, Johnson J, Estes R, David C, Grumet C, Terasaki P, McLeod R (1996b) Toxoplasmosis suseeptibility genes (manuseript in preparation)

    Google Scholar 

  • Marraek P, Kappier J (1994) Subversion of the immune system by pathogens. Cell 76:323–332

    Article  Google Scholar 

  • Marrack P, Kushnir E, Kappier J (1991) A naturally inherited superantigen encoded bya mammary tumour virus. Nature 349:524–526

    Article  PubMed  CAS  Google Scholar 

  • McAuley J, Boyer K, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, McLeod R (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chieago collaborative treatment trial. Clin Inf Dis 18:38–72

    Article  CAS  Google Scholar 

  • McCabe RE, Brooks RG, Dorfman RF, Remington JS (1987) Clinical speetrum in 107 cases of toxoplasmie Iymphadenopathy. Rev Infect Dis 9:754–774

    Article  PubMed  CAS  Google Scholar 

  • McLeod R, Cohen H, Estes R (1984) Immune response to ingested Toxoplasma: deseription of a mouse model of Toxoplasma acquired by ingestion. J Infect Dis 149:234–244

    Article  PubMed  CAS  Google Scholar 

  • McLeod R, Frenkel JK, Estes RG, Maek DG, Eisenhauer P, Gibori G (1988) Subeutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital Toxoplasma ehallenge. J Immunol 140:1632–1637

    PubMed  CAS  Google Scholar 

  • McLeod R, Eisenhauer P, Mack DG, Filice G, Spitalny G (1989a) Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol 142:3247–3255

    PubMed  CAS  Google Scholar 

  • McLeod R, Skamene E, Brown CR, Eisenhauer P, Mack D (1989b) Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection ofAXB/BXA recombinant inbred and B10 congenic mice. J Immunol 143:3031–3034

    PubMed  CAS  Google Scholar 

  • McLeod R, Maek DG, Brown C, Skamene E (1993a) Secretory IgA antibody to SAG 1, H-2 class I restrieted CD8+ T-Iymphoeytes and the INT-1 loeus in proteetion against Toxoplasma gondii. In: Smith J (ed) Toxoplasmosis. NATO ASI Series H. Cell Biology; vol. 78. Springer, Berlin, Heidelberg, New York, pp 131–151

    Google Scholar 

  • McLeod R, Brown C, Mack D (1993b) Immunogenetics influence outcome of T. gondii infeetion. Res Immunol Ann Inst Pasteur 144:61–66

    CAS  Google Scholar 

  • McLeod R, Bushman E, Arbuckle D, Skamene E (1995) Immunogeneties in the analysis of resistanee to intraeellular pathogens. Curr Opin Immunol 7:539–552

    Article  PubMed  CAS  Google Scholar 

  • Mets M, Holfels E, McLeod R, and the Toxoplasmosis Study Group (1992) Ophthalmologic findings in congenital toxoplasmosis. Invest Ophthal Vis Sci 33:4

    Google Scholar 

  • Mets M, Holfels E, McLeod R, and the Toxoplasmosis Study Group (1996) The eye manifestations of toxoplasmosis. Am J Ophthalmol (in press)

    Google Scholar 

  • Miyahira Y, Murata K, Rodriguez D, Rodriguez JR, Esteban M, Rodrigues M, Zavala F (1995) Quantification of antigen specific CD8+ T cells using an ELLISPOT assay. J Immunol Method 181:45–54

    Article  CAS  Google Scholar 

  • Montoya G, Remington J (1995) Studies on the serodiagnosis of toxoplasmic lymphadenitis. Clin Inf Dis 20:781–789

    Article  CAS  Google Scholar 

  • Nadeau JH, Arbuckle LD, Skamene E (1995) Genetic dissection of inflammatory responses. J Inflamm 45:27–48

    PubMed  CAS  Google Scholar 

  • Paigen K (1995) A miracle enough: the power of mice. Nature Med 1:215–220

    Article  PubMed  CAS  Google Scholar 

  • Pamer EG, Harty JT, Bevan PNJ (1991) Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852–855

    Article  PubMed  CAS  Google Scholar 

  • Remington JS, McLeod R, Desmonts G (1995) Congenital Toxoplasmosis. In: Remington JS, Klein J (eds) Infections of the fetus and newborn infant. Saunders, Philadelphia, 140–268

    Google Scholar 

  • Roberts CW, Cruickshank SM, Alexander J (1995) Sex determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun 63:2549–2555

    PubMed  CAS  Google Scholar 

  • Roberts CW, Ferguson DJP, Jebbari H, Satoskar A, Bluethmann H, Alexander J (1996) Different roles for IL4 during the course of Toxoplasma gondii infection. Infect Immun 64:897–904

    PubMed  CAS  Google Scholar 

  • Sher A, Oswald IP, Hieny S, Gazzinelli RT (1993) Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J Immunol 150:3982–3989

    PubMed  CAS  Google Scholar 

  • Sibley DL, Adams LB, Fukutomi Y, Krahenbuhl JL (1991) Tumor necrosis factor-± triggers antitoxoplasmal activity of IFN-γ primed macrophages. J Immunol 147:2340–2345

    PubMed  CAS  Google Scholar 

  • Sibley DL, Boothroyd J (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359:82–85

    Article  PubMed  CAS  Google Scholar 

  • Suzuki Y, Joh K (1994) Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to IFN-γ. Parasitol Res 80: 125–130

    Article  PubMed  CAS  Google Scholar 

  • Suzuki Y, Remington JS (1993) Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection. Infect Immun 61:2264–2288.

    Google Scholar 

  • Suzuki Y, Conley F, Remington JS (1989) Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii. J Infec Dis 159:790–793

    Article  CAS  Google Scholar 

  • Suzuki Y, John K, Orellana MA, Conley FK, Remington JS (1991) A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74:732–739

    PubMed  CAS  Google Scholar 

  • Suzuki Y, Joh K, Kwon OC, Yang Q, Conley FK, Remington JS (1994) MHC class I gene(s) in the D/L region but not the TNF-± gene determines development of toxoplasmic encephalitis in mice. J Immun 97:4649–4654

    Google Scholar 

  • Townsend JJ, Wolinsky JS, Barringer JR, Johnson PC (1975) Acquired toxoplasmosis. Arch Neurol 32:335–343

    Article  PubMed  CAS  Google Scholar 

  • Williams DM, Grumet FC, Remington JS (1978) Genetic control of murine resistance to Toxoplasma gondii. Infect Immun 9:416–420

    Google Scholar 

  • Zanelli E, Gonzalez-Gay MA, David CS (1995) Could HLA-DRI be the protective locus in rheumatoid arthritis? Immunol Today 16:274–278

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McLeod, R., Johnson, J., Estes, R., Mack, D. (1996). Immunogenetics in Pathogenesis of and Protection Against Toxoplasmosis. In: Gross, U. (eds) Toxoplasma gondii. Current Topics in Microbiology and Immunology, vol 219. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-51014-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-51014-4_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-51016-8

  • Online ISBN: 978-3-642-51014-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics